Journal Home Online First Current Issue Archive For Authors Journal Information 中文版

This Issue

2022, Vol.16, Issue.5

Contents Volume 16 · Issue 5 · 2022. Pages 667-826 14 articles

All Export << Previous issue | Next issue >>

Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 667-685 doi:10.1007/s11684-022-0960-z

Abstract 69 PDF 22

Recent advances in systemic lupus erythematosus and microbiota: from bench to bedside

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 686-700 doi:10.1007/s11684-022-0957-7

Abstract 40 PDF 4

Targeting apoptosis to manage acquired resistance to third generation EGFR inhibitors

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 701-713 doi:10.1007/s11684-022-0951-0

Abstract 33 PDF 28

Increased expression of coronin-1a in amyotrophic lateral sclerosis: a potential diagnostic biomarker and therapeutic target

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 723-735 doi:10.1007/s11684-021-0905-y

Abstract 71 PDF 5

Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 773-783 doi:10.1007/s11684-021-0902-1

Abstract 121 PDF 11

Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in GNAQ/11-mutant uveal melanoma

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 784-798 doi:10.1007/s11684-021-0911-0

Abstract 67 PDF 18

Mycophenolate mofetil or tacrolimus compared with azathioprine in long-term maintenance treatment for active lupus nephritis

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 799-807 doi:10.1007/s11684-021-0849-2

Abstract 43 PDF 2

Novel variants in LAMA3 and COL7A1 and recurrent variant in KRT5 underlying epidermolysis bullosa in five Chinese families

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 808-814 doi:10.1007/s11684-021-0878-x

Abstract 89 PDF 1

Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 815-826 doi:10.1007/s11684-021-0891-0

Abstract 75 PDF 31